Drug metabolism and pancreatic cancer.

Abstract

Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient's individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality.

• Authors: John Paul E Flores, Robert B Diasio, Muhammad Wasif Saif
• Journal: Annals of gastroenterology (Ann Gastroenterol) Vol. 30 Issue 1 Pg. 54-61 ( 2017) ISSN: 1108-7471 [Print] Greece
• PMID: 28042238 (Publication Type: Review, Journal Article)